New approach aims to stop dangerous bleeding after C-Sections
NCT ID NCT07188207
Summary
This study is testing if adding a medication called misoprostol, given as a rectal suppository, to the standard treatment (oxytocin) can better reduce blood loss during and after a planned cesarean section. It will compare two groups of women: one gets the standard treatment alone, and the other gets the standard treatment plus the rectal medication. The goal is to find a safe, effective, and affordable way to prevent dangerous postpartum bleeding, especially in areas with limited medical resources.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTPARTUM HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.